Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors
The study of safety of ZIO-201-T in combination with doxorubicin in the treatment of advanced cancer.
Advanced Cancer
DRUG: ZIO-201-T and doxorubicin
Toxicities, 5 months
Pharmacokinetics, 5 months
The study of safety of ZIO-201-T in combination with doxorubicin in the treatment of advanced cancer.